Subscribe

What are you looking for?

Main Menu

明報新聞網

榮昌生物就其注射液訂立許可協議 股價曾升逾5%

Future Wealths
Future Wealths
19 8 月, 2025
One Min Read
10 Views
0 Comments
榮昌生物(9995)公布，與參天中國訂立許可協議，公司將取得2.5億元人民幣(下同)首付款、最高5.2億元開發及監管里程碑付款；及最高5.25億元銷售里程碑付款，以及銷售分成。股價曾升逾5%。

原文: https://finance.mingpao.com/fin/instantf/20250819/1755569497829/%e6%a6%ae%e6%98%8c%e7%94%9f%e7%89%a9%e5%b0%b1%e5%85%b6%e6%b3%a8%e5%b0%84%e6%b6%b2%e8%a8%82%e7%ab%8b%e8%a8%b1%e5%8f%af%e5%8d%94%e8%ad%b0-%e8%82%a1%e5%83%b9%e6%9b%be%e5%8d%87%e9%80%be5

Last Update: 19 8 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept